Message From the Chief
Moving Ahead: From COVID-19 to Lung Cancer Screening
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
Our new lung transplantation program, with a special expertise in multiorgan, bloodless, and HIV-positive transplants, will help the many people whose lung function was devastated by SARS-CoV-2. And a new initiative, known as RECOVER, will assess the post-acute sequelae of SARS-CoV-2 infection, with a special focus on the respiratory system. The goal of this National Institutes of Health study is to recruit more than 17,000 patients across 15 hub sites, assess their clinical symptomatology following infection, and then follow them to see what occurs clinically over the long term after infection and how it occurs.